Sunshine Biopharma Inc. (SBFM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$556.2K2012: -$706.7K2013: -$1.94M2014: -$1.76M2015: -$780.3K2016: -$993.1K2017: -$857.2K2018: -$1.16M2019: -$641.6K2020: -$576.9K2021: -$2.44M2022: -$27.00M2023: -$4.79M2024: -$5.81M2025: -$6.23M-$6.23M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$6.23M-7.1%
2024-$5.81M-21.5%
2023-$4.79M+82.3%
2022-$27.00M-1006.5%
2021-$2.44M-323.0%
2020-$576.9K+10.1%
2019-$641.6K+44.9%
2018-$1.16M-35.8%
2017-$857.2K+13.7%
2016-$993.1K-27.3%
2015-$780.3K+55.5%
2014-$1.76M+9.3%
2013-$1.94M-174.0%
2012-$706.7K-27.1%
2011-$556.2K